Michelle I Lin
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Emily N Price
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Sonja Boatman
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Elliott J Hagedorn
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Eirini Trompouki
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Sruthi Satishchandran
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Charles W Carspecken
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Audrey Uong
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Anthony DiBiase
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Song Yang
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Matthew C Canver
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Ann Dahlberg
Pediatric Oncology, Clinical Division, Fred Hutchinson Cancer Research Center, Seattle, United States
Competing interests
No competing interests declared.
Zhigang Lu
Department of Physiology, University of Texas Southwestern Medical Center, Dallas, United States
Competing interests
No competing interests declared.
Cheng Cheng Zhang
Department of Physiology and Developmental Biology, University of Texas Southwestern Medical Center, Dallas, United States
Competing interests
No competing interests declared.
Stuart H Orkin
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
No competing interests declared.
Irwin D Bernstein
Pediatric Oncology, Clinical Division, Fred Hutchinson Cancer Research Center, Seattle, United States
Competing interests
No competing interests declared.
Jon C Aster
Department of Pathology, Brigham and Women's Hospital, Boston, United States
Competing interests
No competing interests declared.
Richard M White
Department of Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, United States
Competing interests
No competing interests declared.
Leonard I Zon
Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, United States
Competing interests
Leonard I Zon, I am a founder and stockholder of Fate, Inc. and Scholar Rock, and a scientific advisor for Stemgent.
Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All zebrafish were housed at the Karp Aquatic Resource Program Facility at Boston Children's Hospital. All protocols were approved by the Animal Care and Use Committee at Boston Children's Hospital and by the Institutional Animal Care and Use Committee (protocol 11-10-2069R).
© 2015, Lin et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.